More particularly, a RNA-seq data of patients with lung adenocarcinoma showed that ACE2 was expressed in 59% of cancer samples and only in 25% of adjacent lung normal samples and, among the samples expressing ACE2, the level of the gene was higher in the cancer, compared to the adjacent normal lung tissue (p = 0.0012) [59]. The gene discussed is ACE2; the disease is cancer.